Form 8-K - Current report:
SEC Accession No. 0001023024-06-000028
Filing Date
2006-08-14
Accepted
2006-08-14 14:06:29
Documents
3
Period of Report
2006-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BIOSANTE EARINGS RELEASE 8/14/06 biosanteq2results.htm 8-K 28734
2 BIOSANTE PRESS RELEASE 8/14/06 pressrelease.htm EX-99.1 13195
3 LOGO pressrelease1.jpg GRAPHIC 7689
  Complete submission text file 0001023024-06-000028.txt   54313
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 061028920
SIC: 2836 Biological Products, (No Diagnostic Substances)